| P50 | author | Oliver Riesterer | Q64681374 |
| P2093 | author name string | Bernhard Odermatt | |
| | I Frank Ciernik | |
| | Ferdinando Cerciello | |
| | Mohamed Sherweif | |
| P2860 | cites work | Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 |
| | Review of epidermal growth factor receptor biology | Q34320636 |
| | Epidermal growth factor receptor inhibition strategies in oncology | Q34378885 |
| | EGFR and cancer prognosis | Q34399312 |
| | EGF receptor targeting in therapy-resistant human tumors | Q34750359 |
| | Combined-modality therapy of locally advanced cervical cancer | Q35125954 |
| | Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy | Q35669130 |
| | Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies | Q35669133 |
| | Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results | Q35902858 |
| | Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies | Q36046225 |
| | Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced ce | Q38612684 |
| | Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice | Q40396271 |
| | Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo. | Q40451001 |
| | EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor | Q44306493 |
| | Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer | Q45073535 |
| | Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopatho | Q46598246 |
| | Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy | Q47800601 |
| | Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis | Q47872633 |
| | Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. | Q51988092 |
| | The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. | Q52004398 |
| | The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. | Q53359192 |
| | G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. | Q53665577 |
| | Epidermal Growth Factor Receptor Expression in Pretreatment Biopsies From Head and Neck Squamous Cell Carcinoma As a Predictive Factor for a Benefit From Accelerated Radiation Therapy in a Randomized Controlled Trial | Q57618379 |
| | c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix | Q72666313 |
| | Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation | Q73428673 |
| | Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer | Q77321070 |
| | Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix | Q77337863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 394-399 | |
| P577 | publication date | 2007-05-23 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Is EGFR a moving target during radiotherapy of carcinoma of the uterine cervix? | |
| P478 | volume | 106 | |